Christopher Burge, 34, couldn't recall the last time he "felt 100%." Then he noticed bowel changes. Soon after, he was ...
The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...